Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer

British Journal of Cancer

Volumn 83, Issue 9, 2000, Pages 1128-1135

  Sculier, J P ^a   Lafitte, J J ^a   Paesmans, M ^a   Thiriaux, J ^a   Alexopoulos, C G ^a   Baumohl J ^a   Schmerber, J ^a   Koumakis, G ^a   Florin, M C ^a   Zacharias, C ^a   Berghmans, T ^a   Mommen, P ^a   Ninane, V ^a   Klastersky, J ^a  

^a JULES BORDET INSTITUTE   (Belgium)

Author keywords

Cisplatin; Non small cell lung cancer; Randomized trial; Stage IV

Indexed keywords

CARBOPLATIN; CISPLATIN; IFOSFAMIDE; MESNA; MITOMYCIN;

ALOPECIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; LEUKOPENIA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL TIME; THROMBOCYTOPENIA; VOMITING;

EID: 0033764530     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2000.1413     Document Type: Article

References (43)

1. Combination chemotherapy versus single agents followed by combination chemotherapy in stage iv non-small-cell lung cancer: A study of the Eastern Cooperative Oncology Group
2. Prognostic factors for response to chemotherapy containing platinum derivatives in patients with unresectable non-small cell lung cancer (NSCLC)
3. Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: A randomized phase III study of the italian Lung Cancer Project
4. A randomized trial of three cisplatin-containing regimens in advanced non-small-cell lung cancer (NSCLC): A study of the Umbrian Lung Cancer Group
5. Mitomycin, ifosfamide, and cisplatin in unresectable non-small-cell lung cancer: Effects on survival and quality of life
6. Mitomycin, ifosfamide and cisplatin in non-small cell lung cancer: Treatment good enough to compare
7. Vinorelbine versus vinorelbine plus cisplatin in advanced non-small-cell lung cancer: A randomized trial
8. Chimiotherapie des cancers bronchiques non a petites cellules. Meta-analyse de la litterature en fonction de l'extension de la maladie
9. Random prospective study of vindesine versus vindesine plus high-dose cisplatin versus vindesine plus cisplatine plus mitomycin C in advanced non-small-cell lung cancer
10. Vindesine and cisplatin combination chemotherapy compared with vindesine as a single agent in the management of non-small cell lung cancer: A randomized study
11. Randomized study of cyclophosphamide, doxorubicin, and etoposide (V16-213) with or without cisplatinum in non-small cell lung cancer
12. A randomized trial in inoperable non-small-cell lung cancer: Vindesine and cisplatin versus mitomycin, vindesine, and cisplatin versus etoposide and cisplatin alternating with vindesine and mitomycin
13. Evaluation of cisplatin intensity in metastatic non-small-cell lung cancer: A phase III study of the Southwest Oncology Group
14. Randomized study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non-small-cell lung cancer. The European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group
15. Cisplatin and vindesine combination chemotherapy for advanced carcinoma of the lung: A randomized trial investigating two dosage schedules
16. Chemotherapy for advanced non-small-cell lung cancer: How much benefit is enough?
17. Counting the costs of chemotherapy in a National Cancer Institute of Canada randomized trial in non small-cell lung cancer
18. A randomized study of cisplatin versus cisplatin plus vindesine for non-small cell lung carcinoma
19. Cisplatin versus cisplatin plus etoposide in the treatment of advanced non-small-cell lung cancer
20. A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small-cell lung cancer: European Organization for Research and Treatment of Cancer protocol 07861
21. A randomized study comparing a high and a standard dose of cisplatin in combination with etoposide in the treatment of advanced non-small-cell lung carcinoma
22. Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: Results of a European multicenter trial including 612 patients
23. Randomized comparison of two combination regimens versus minimal chemotherapy in non-small cell lung cancer: A Southeastern Cancer Study Group trial
24. Chemotherapy vs supportive care in advanced non-small cell lung cancer. Results of a meta-analysis of the literature
25. Phase II and III studies with new drugs for non-small cell lung cancer. A systematic review of the literature with a methodology quality assessment
26. A randomized prospective study of cisplatin and vinblastine versus cisplatin, vinblastine and mitomycin in advanced non-small cell lung cancer
27. Facteurs pronostiques des cancers bronchopulmonaries
28. Prognostic factors for survival in advanced non small cell lung cancer; uni and multivariate analyses including recpam analysis in 1052 patients
29. Response to chemotherapy has a discriminant value on the distribution of further survival for patients with advanced non small cell lung cancer: A ten years experience of the European Lung Cancer Working Party
30. Randomized phase III comparison of three doxorubicin-based chemotherapy regimens in advanced non-small cell lung cancer: A Southeastern Cancer Study Group trial
31. Etoposide versus etoposide plus high-dose cisplatin in the management of advanced non-small cell lung cancer
32. Best supportive care or chemotherapy for stage IV non small cell lung cancer
33. Phase II randomized trial comparing high-dose cisplatin with moderate-dose cisplatin and carboplatin in patients with advanced non-small-cell lung cancer
34. A randomized trial comparing induction chemotherapy versus induction chemotherapy followed by maintenance chemotherapy in small cell lung cancer
35. Long-term survival after chemotherapy containing platinum derivatives in patients with advanced unresectable non small cell lung cancer
36. Phase III randomized trial comparing cisplatin and carboplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer
37. A comparison of methods of calculation for estimating carboplatin AUC with a retrospective pharmacokinetic-pharmacodynamic analysis in patients with advanced non-small cell lung cancer
38. A randomized clinical trial of vindesine plus cisplatin versus mitomycin plus vindesine and cisplatin in advanced non-small cell lung cancer
39. Cisplatin and vindesine combination chemotherapy for non-small cell lung cancer: A randomized trial comparing two dosages of cisplatin
40. Polychemotherapy in advanced non-small-cell lung cancer: A metaanalysis
41. Relationship between quality of life and clinical outcomes in advanced non-small cell lung cancer: Best supportive care (BSC) versus BSC plus chemotherapy
42. A randomized trial of five cisplatin-containing treatments in patients with metastatic non-small-cell lung cancer: A Southwest Oncology Group Study
43. Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: A Southwest Oncology Group study